Efron Paul (CIK 2024711) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-04). Recent activity: Buy NONE (3,580 shares), Sell NONE (825 shares), Buy NONE (7,692 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-04 | Keenova Therapeutics plc (NONE) | Director | Buy | 3,580 | $0 |
| 2026-06-04 | Keenova Therapeutics plc (NONE) | Director | Sell | 825 | $0 |
| 2025-08-18 | Mallinckrodt plc (NONE) | Director | Buy | 7,692 | $709,972 |
来源：SEC Form 4 申报文件 · 截至 2026-06-04